Trends in prevalence and burden of depressive disorders in Iran at national and subnational levels: estimates based on sex and age groups
BackgroundMental disorders rank among the leading contributors to the global disease burden, with depressive disorders being among the most prevalent.AimsThe objective of this study is to examine the prevalence, incidence and years lived with disability (YLDs) associated with depressive disorders, p...
Uloženo v:
| Vydáno v: | General psychiatry Ročník 38; číslo 3; s. e102016 |
|---|---|
| Hlavní autoři: | , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
England
BMJ Publishing Group Ltd
20.06.2025
BMJ Publishing Group LTD BMJ Publishing Group |
| Témata: | |
| ISSN: | 2517-729X, 2096-5923, 2517-729X |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | BackgroundMental disorders rank among the leading contributors to the global disease burden, with depressive disorders being among the most prevalent.AimsThe objective of this study is to examine the prevalence, incidence and years lived with disability (YLDs) associated with depressive disorders, particularly major depressive disorder and dysthymia, in Iran from 1990 to 2021. To achieve this, the research focused on analysing these metrics across various dimensions, including temporal trends, sex differences, age categories and subnational regions.MethodsThe data used in this study are sourced directly from the Institute for Health Metrics and Evaluation, ensuring that the information is both authoritative and reliable. All-age count estimates and age-standardised rates (per 100 000) were calculated for prevalence, incidence and YLDs. The disease burden indicators were analysed for the period spanning from 1990 to 2021, stratified by sex, age and location. The percentage change between 1990 and 2021 was also documented. The 95% uncertainty interval (UI) was reported for each of the reported estimates.ResultsThe prevalence of depressive disorders in Iran demonstrated a notable upward trend from 1990 to 2021, with the rate of growth being particularly pronounced within the country. The age-standardised prevalence rate per 100 000 individuals for depressive disorders in Iran was 5609 (95% UI 4810 to 6488). By 2021, the number of depression cases in Iran reached 5.2 million, which is approximately 2.37 times the figure reported in 1990. The prevalence of depressive disorders was notably higher among females compared with males. The age-standardised prevalence rate per 100 000 individuals for males was 4184 (95% UI 3545 to 4929). For females, this figure was significantly greater, reaching 7077 (95% UI 6115 to 8172). Out of the total reported cases of depressive disorders in Iran, 3.2 million were observed in females, while males accounted for 2 million cases.ConclusionsThe findings highlighted the considerable impact of depressive disorders in Iran, both nationally and regionally, while also revealing variations across sex and age groups. Given the shifts in the demographic structure and the growing burden of these disorders, it is essential to prioritise screening initiatives, education programmes and strategies aimed at enhancing mental health awareness and ensuring improved access to mental health services in health policy planning. |
|---|---|
| AbstractList | Mental disorders rank among the leading contributors to the global disease burden, with depressive disorders being among the most prevalent.
The objective of this study is to examine the prevalence, incidence and years lived with disability (YLDs) associated with depressive disorders, particularly major depressive disorder and dysthymia, in Iran from 1990 to 2021. To achieve this, the research focused on analysing these metrics across various dimensions, including temporal trends, sex differences, age categories and subnational regions.
The data used in this study are sourced directly from the Institute for Health Metrics and Evaluation, ensuring that the information is both authoritative and reliable. All-age count estimates and age-standardised rates (per 100 000) were calculated for prevalence, incidence and YLDs. The disease burden indicators were analysed for the period spanning from 1990 to 2021, stratified by sex, age and location. The percentage change between 1990 and 2021 was also documented. The 95% uncertainty interval (UI) was reported for each of the reported estimates.
The prevalence of depressive disorders in Iran demonstrated a notable upward trend from 1990 to 2021, with the rate of growth being particularly pronounced within the country. The age-standardised prevalence rate per 100 000 individuals for depressive disorders in Iran was 5609 (95% UI 4810 to 6488). By 2021, the number of depression cases in Iran reached 5.2 million, which is approximately 2.37 times the figure reported in 1990. The prevalence of depressive disorders was notably higher among females compared with males. The age-standardised prevalence rate per 100 000 individuals for males was 4184 (95% UI 3545 to 4929). For females, this figure was significantly greater, reaching 7077 (95% UI 6115 to 8172). Out of the total reported cases of depressive disorders in Iran, 3.2 million were observed in females, while males accounted for 2 million cases.
The findings highlighted the considerable impact of depressive disorders in Iran, both nationally and regionally, while also revealing variations across sex and age groups. Given the shifts in the demographic structure and the growing burden of these disorders, it is essential to prioritise screening initiatives, education programmes and strategies aimed at enhancing mental health awareness and ensuring improved access to mental health services in health policy planning. Mental disorders rank among the leading contributors to the global disease burden, with depressive disorders being among the most prevalent.BackgroundMental disorders rank among the leading contributors to the global disease burden, with depressive disorders being among the most prevalent.The objective of this study is to examine the prevalence, incidence and years lived with disability (YLDs) associated with depressive disorders, particularly major depressive disorder and dysthymia, in Iran from 1990 to 2021. To achieve this, the research focused on analysing these metrics across various dimensions, including temporal trends, sex differences, age categories and subnational regions.AimsThe objective of this study is to examine the prevalence, incidence and years lived with disability (YLDs) associated with depressive disorders, particularly major depressive disorder and dysthymia, in Iran from 1990 to 2021. To achieve this, the research focused on analysing these metrics across various dimensions, including temporal trends, sex differences, age categories and subnational regions.The data used in this study are sourced directly from the Institute for Health Metrics and Evaluation, ensuring that the information is both authoritative and reliable. All-age count estimates and age-standardised rates (per 100 000) were calculated for prevalence, incidence and YLDs. The disease burden indicators were analysed for the period spanning from 1990 to 2021, stratified by sex, age and location. The percentage change between 1990 and 2021 was also documented. The 95% uncertainty interval (UI) was reported for each of the reported estimates.MethodsThe data used in this study are sourced directly from the Institute for Health Metrics and Evaluation, ensuring that the information is both authoritative and reliable. All-age count estimates and age-standardised rates (per 100 000) were calculated for prevalence, incidence and YLDs. The disease burden indicators were analysed for the period spanning from 1990 to 2021, stratified by sex, age and location. The percentage change between 1990 and 2021 was also documented. The 95% uncertainty interval (UI) was reported for each of the reported estimates.The prevalence of depressive disorders in Iran demonstrated a notable upward trend from 1990 to 2021, with the rate of growth being particularly pronounced within the country. The age-standardised prevalence rate per 100 000 individuals for depressive disorders in Iran was 5609 (95% UI 4810 to 6488). By 2021, the number of depression cases in Iran reached 5.2 million, which is approximately 2.37 times the figure reported in 1990. The prevalence of depressive disorders was notably higher among females compared with males. The age-standardised prevalence rate per 100 000 individuals for males was 4184 (95% UI 3545 to 4929). For females, this figure was significantly greater, reaching 7077 (95% UI 6115 to 8172). Out of the total reported cases of depressive disorders in Iran, 3.2 million were observed in females, while males accounted for 2 million cases.ResultsThe prevalence of depressive disorders in Iran demonstrated a notable upward trend from 1990 to 2021, with the rate of growth being particularly pronounced within the country. The age-standardised prevalence rate per 100 000 individuals for depressive disorders in Iran was 5609 (95% UI 4810 to 6488). By 2021, the number of depression cases in Iran reached 5.2 million, which is approximately 2.37 times the figure reported in 1990. The prevalence of depressive disorders was notably higher among females compared with males. The age-standardised prevalence rate per 100 000 individuals for males was 4184 (95% UI 3545 to 4929). For females, this figure was significantly greater, reaching 7077 (95% UI 6115 to 8172). Out of the total reported cases of depressive disorders in Iran, 3.2 million were observed in females, while males accounted for 2 million cases.The findings highlighted the considerable impact of depressive disorders in Iran, both nationally and regionally, while also revealing variations across sex and age groups. Given the shifts in the demographic structure and the growing burden of these disorders, it is essential to prioritise screening initiatives, education programmes and strategies aimed at enhancing mental health awareness and ensuring improved access to mental health services in health policy planning.ConclusionsThe findings highlighted the considerable impact of depressive disorders in Iran, both nationally and regionally, while also revealing variations across sex and age groups. Given the shifts in the demographic structure and the growing burden of these disorders, it is essential to prioritise screening initiatives, education programmes and strategies aimed at enhancing mental health awareness and ensuring improved access to mental health services in health policy planning. BackgroundMental disorders rank among the leading contributors to the global disease burden, with depressive disorders being among the most prevalent.AimsThe objective of this study is to examine the prevalence, incidence and years lived with disability (YLDs) associated with depressive disorders, particularly major depressive disorder and dysthymia, in Iran from 1990 to 2021. To achieve this, the research focused on analysing these metrics across various dimensions, including temporal trends, sex differences, age categories and subnational regions.MethodsThe data used in this study are sourced directly from the Institute for Health Metrics and Evaluation, ensuring that the information is both authoritative and reliable. All-age count estimates and age-standardised rates (per 100 000) were calculated for prevalence, incidence and YLDs. The disease burden indicators were analysed for the period spanning from 1990 to 2021, stratified by sex, age and location. The percentage change between 1990 and 2021 was also documented. The 95% uncertainty interval (UI) was reported for each of the reported estimates.ResultsThe prevalence of depressive disorders in Iran demonstrated a notable upward trend from 1990 to 2021, with the rate of growth being particularly pronounced within the country. The age-standardised prevalence rate per 100 000 individuals for depressive disorders in Iran was 5609 (95% UI 4810 to 6488). By 2021, the number of depression cases in Iran reached 5.2 million, which is approximately 2.37 times the figure reported in 1990. The prevalence of depressive disorders was notably higher among females compared with males. The age-standardised prevalence rate per 100 000 individuals for males was 4184 (95% UI 3545 to 4929). For females, this figure was significantly greater, reaching 7077 (95% UI 6115 to 8172). Out of the total reported cases of depressive disorders in Iran, 3.2 million were observed in females, while males accounted for 2 million cases.ConclusionsThe findings highlighted the considerable impact of depressive disorders in Iran, both nationally and regionally, while also revealing variations across sex and age groups. Given the shifts in the demographic structure and the growing burden of these disorders, it is essential to prioritise screening initiatives, education programmes and strategies aimed at enhancing mental health awareness and ensuring improved access to mental health services in health policy planning. Background Mental disorders rank among the leading contributors to the global disease burden, with depressive disorders being among the most prevalent.Aims The objective of this study is to examine the prevalence, incidence and years lived with disability (YLDs) associated with depressive disorders, particularly major depressive disorder and dysthymia, in Iran from 1990 to 2021. To achieve this, the research focused on analysing these metrics across various dimensions, including temporal trends, sex differences, age categories and subnational regions.Methods The data used in this study are sourced directly from the Institute for Health Metrics and Evaluation, ensuring that the information is both authoritative and reliable. All-age count estimates and age-standardised rates (per 100 000) were calculated for prevalence, incidence and YLDs. The disease burden indicators were analysed for the period spanning from 1990 to 2021, stratified by sex, age and location. The percentage change between 1990 and 2021 was also documented. The 95% uncertainty interval (UI) was reported for each of the reported estimates.Results The prevalence of depressive disorders in Iran demonstrated a notable upward trend from 1990 to 2021, with the rate of growth being particularly pronounced within the country. The age-standardised prevalence rate per 100 000 individuals for depressive disorders in Iran was 5609 (95% UI 4810 to 6488). By 2021, the number of depression cases in Iran reached 5.2 million, which is approximately 2.37 times the figure reported in 1990. The prevalence of depressive disorders was notably higher among females compared with males. The age-standardised prevalence rate per 100 000 individuals for males was 4184 (95% UI 3545 to 4929). For females, this figure was significantly greater, reaching 7077 (95% UI 6115 to 8172). Out of the total reported cases of depressive disorders in Iran, 3.2 million were observed in females, while males accounted for 2 million cases.Conclusions The findings highlighted the considerable impact of depressive disorders in Iran, both nationally and regionally, while also revealing variations across sex and age groups. Given the shifts in the demographic structure and the growing burden of these disorders, it is essential to prioritise screening initiatives, education programmes and strategies aimed at enhancing mental health awareness and ensuring improved access to mental health services in health policy planning. |
| Author | Amiri, Sohrab Khan, Moien A B |
| Author_xml | – sequence: 1 givenname: Sohrab orcidid: 0000-0003-0297-0142 surname: Amiri fullname: Amiri, Sohrab organization: Spiritual Health Research Center, Lifestyle Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran – sequence: 2 givenname: Moien A B surname: Khan fullname: Khan, Moien A B email: moien.khan@uaeu.ac.ae organization: Health and Wellness Research Group, Department of Family Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40547356$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kstu1TAQhiNUREvpC7BAltiwSfElthM2CFVQjlSJTZHYWb5M0hzl2MFOjugj8Na4SXtoWbCyPfP9v0cz87I48sFDUbwm-JwQJt53Y7q1NyXFtCoJppiIZ8UJ5USWkjY_jh7dj4uzlLYYY0qIkHXzojiuMK8k4-Kk-H0dwbuEeo_GCHs9gLeAtHfIzNGBR6FFDnIqpX4PyPUp5HBcBJuoPdIT8nrqg9fDIkuzObwH2MOQPiBIU7_TEyRkdAKHgkcJfi247gB1McxjelU8b_WQ4Oz-PC2-f_l8ffG1vPp2ubn4dFWaqm6m0gmOW-tk7aw0UpKaA5Mai5oKbjjlhrjWGc1B6KrVouKNc5RwYw2TRgvCTovN6uuC3qox5srirQq6V0sgxE7pOPV2AFVzaig2RrpWVBU3NUhrjLNN9mw52Oz1cfUaZ7MDZ8FPUQ9PTJ9mfH-jurBXhJI6j4Nmh3f3DjH8nHOj1K5PFoZBewhzUoxSJhgmVGb07T_oNswx93mhKBdMNixTbx6XdKjlYeQZoCtgY0gpQntACFZ3q6XW1VJ3q6XW1cqi81Vkdtu_3_5H8Ac-uNQ1 |
| Cites_doi | 10.1017/S0033291725000649 10.1016/j.jpsychires.2023.11.047 10.1016/S2215-0366(21)00395-3 10.1007/s00127-023-02587-w 10.1097/JCP.0b013e318205a670 10.1002/eat.23835 10.1016/j.psychres.2023.115668 10.1016/S2214-109X(24)00342-5 10.34171/mjiri.33.9 10.1007/s11682-023-00772-8 10.1016/j.jad.2024.03.074 10.1080/24694193.2025.2472692 10.1016/s0006-3223(02)01349-5 10.1016/S0140-6736(24)00757-8 10.1016/S0140-6736(16)30388-9 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z 10.1002/sim.3733 10.1016/j.psychres.2024.115854 10.4274/balkanmedj.galenos.2024.2023-11-55 10.1016/S0140-6736(24)00933-4 10.1016/j.worlddev.2021.105760 10.1080/00207411.2020.1859347 10.15171/ijhpm.2017.147 10.2147/NDT.S19617 10.1016/S2215-0366(16)30263-2 10.1016/S0140-6736(21)02751-3 10.1016/j.cegh.2024.101536 10.1111/jcpp.13202 10.1016/j.jad.2023.04.024 10.1192/bjp.bp.105.020040 10.1136/gpsych-2024-101596 10.1186/s12991-023-00486-7 10.37796/2211-8039.1003 10.1001/archpsyc.1994.03950010008002 10.1176/appi.ajp.160.6.1147 10.1016/S0140-6736(18)33197-0 10.1016/j.labeco.2024.102581 10.1080/10803548.2021.1954793 10.1016/S0140-6736(21)02143-7 10.1016/j.psychres.2024.115958 10.1016/s0006-3223(02)01410-5 10.1016/s0140-6736(24)00757-8 10.1016/S0006-3223(02)01410-5 10.1136/bmj.i1617 10.1016/s0140-6736(24)00933-4 10.1016/S0006-3223(02)01349-5 10.1016/s2215-0366(21)00395-3 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z |
| ContentType | Journal Article |
| Copyright | Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. 2025. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. 2025 |
| Copyright_xml | – notice: Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. – notice: Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. – notice: 2025. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. 2025 |
| DBID | 9YT ACMMV AAYXX CITATION NPM 3V. 7XB 88G 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH GNUQQ GUQSH M2M M2O MBDVC PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 5PM DOA |
| DOI | 10.1136/gpsych-2024-102016 |
| DatabaseName | BMJ Open Access Journals BMJ Journals:Open Access CrossRef PubMed ProQuest Central (Corporate) ProQuest Central (purchase pre-March 2016) Psychology Database (Alumni) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Coronavirus Research Database ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep Psychology Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China One Psychology ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) ProQuest One Community College Research Library (Alumni Edition) ProQuest Central China ProQuest Central Health Research Premium Collection ProQuest Central Korea ProQuest Research Library ProQuest Central (New) ProQuest Central Basic ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2517-729X |
| ExternalDocumentID | oai_doaj_org_article_852b20bb7df6445b8e7cbbdc99ddf5ec PMC12182112 40547356 10_1136_gpsych_2024_102016 gpsych |
| Genre | Journal Article |
| GeographicLocations | Iran |
| GeographicLocations_xml | – name: Iran |
| GroupedDBID | 5VR 8FI 8FJ 8G5 9YT AAFWJ ABUWG ACMMV ADBBV AFKRA AFPKN ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BCNDV BENPR CCPQU DWQXO FYUFA GNUQQ GROUPED_DOAJ GUQSH HYE M2M M2O OK1 PHGZM PHGZT PIMPY PSYQQ RMJ RPM UKHRP 9D9 9DE AAYXX AFUIB CITATION TCJ TGQ NPM 3V. 7XB 8FK COVID MBDVC PKEHL PQEST PQQKQ PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-b489t-d650fcd78dc7b77185e37a068265b525b1dfdba5e6a4fa6459dd215bcb37ba613 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 1 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001513859000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2517-729X 2096-5923 |
| IngestDate | Fri Oct 03 12:52:20 EDT 2025 Tue Nov 04 02:03:31 EST 2025 Fri Sep 05 15:50:09 EDT 2025 Mon Jun 30 07:23:06 EDT 2025 Thu Jun 26 01:39:31 EDT 2025 Sun Nov 09 14:49:15 EST 2025 Fri Jun 20 17:21:19 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Depression Global Burden of Disease Depressive Disorder Prevalence Incidence |
| Language | English |
| License | This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-b489t-d650fcd78dc7b77185e37a068265b525b1dfdba5e6a4fa6459dd215bcb37ba613 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Additional supplemental material is published online only. To view, please visit the journal online (https://doi.org/10.1136/gpsych-2024-102016). Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise. None declared. |
| ORCID | 0000-0003-0297-0142 |
| OpenAccessLink | https://doaj.org/article/852b20bb7df6445b8e7cbbdc99ddf5ec |
| PMID | 40547356 |
| PQID | 3222563793 |
| PQPubID | 4758913 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_852b20bb7df6445b8e7cbbdc99ddf5ec pubmedcentral_primary_oai_pubmedcentral_nih_gov_12182112 proquest_miscellaneous_3223630127 proquest_journals_3222563793 pubmed_primary_40547356 crossref_primary_10_1136_gpsych_2024_102016 bmj_journals_10_1136_gpsych_2024_102016 |
| PublicationCentury | 2000 |
| PublicationDate | 2025-06-20 |
| PublicationDateYYYYMMDD | 2025-06-20 |
| PublicationDate_xml | – month: 06 year: 2025 text: 2025-06-20 day: 20 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London – name: BMA House, Tavistock Square, London, WC1H 9JR |
| PublicationTitle | General psychiatry |
| PublicationTitleAbbrev | Gen Psych General Psychiatry |
| PublicationTitleAlternate | Gen Psychiatr |
| PublicationYear | 2025 |
| Publisher | BMJ Publishing Group Ltd BMJ Publishing Group LTD BMJ Publishing Group |
| Publisher_xml | – name: BMJ Publishing Group Ltd – name: BMJ Publishing Group LTD – name: BMJ Publishing Group |
| References | Khademi, Hosseini, Nia (R48) 2020; 10 Dwyer, Stringaris, Brent (R5) 2020; 61 Yan, Zhang, Wang (R11) 2024; 337 Lai (R49) 2011; 31 Krishnan (R24) 2002; 52 Zhao, Li, Zhang (R29) 2024; 170 Lépine, Briley (R4) 2011; 7 Sajadi, Ehsani-Chimeh, Majdzadeh (R32) 2019; 33 Kessler, McGonagle, Zhao (R1) 1994; 51 Amiri, AB Khan (R15) 2025; 48 Amirkafi, Mohammadi, Tehrani-Banihashemi (R16) 2024; 59 Mohammadi, Seyedmirzaei, Salehi (R47) 2023; 17 Amiri (R50) 2022; 51 Ghalichi, Shariat, Naserbakht (R17) 2024; 12 Safiri, Noori, Nejadghaderi (R14) 2023; 56 Gao, Cao, Liu (R28) 2024; 331 Balata, Becher, Conrad (R7) 2024; 37 Li, Zhang, Cai (R12) 2023; 22 Alon, Macrynikola, Jester (R22) 2024; 335 Ferrari, Santomauro, Aali (R34) 2024; 403 Lu, Lin, Su (R6) 2024; 354 Gorji (R43) 2014; 43 Kokabisaghi (R33) 2018; 7 Moghaddasi Kelishomi, Nisticò (R44) 2022; 151 Brauer, Roth, Aravkin (R51) 2024; 403 Cole, Dendukuri (R21) 2003; 160 Santomauro, Mantilla Herrera, Shadid (R42) 2021; 398 Amiri (R27) 2022; 28 Kuehner (R46) 2017; 4 Danaei, Farzadfar, Kelishadi (R31) 2019; 393 Rockson, Girish, Harivenkatesh (R20) 2024; 26 Effatpanah, Nakhostin-Ansari, Gorgani (R13) 2024; 41 Kelishomi, Nisticò (R45) 2024; 89 Liu, Ren, Liu (R35) 2025; 55 Bruce (R23) 2002; 52 Clegg, Hankey, Tiwari (R41) 2009; 28 (R36) 2022; 9 Stevens, Alkema, Black (R39) 2016; 388 Peng, Wu, Wen (R19) 2023; 333 Lorant, Croux, Weich (R26) 2007; 190 Kim, Fay, Feuer (R40) 2000; 19 Farzadfar, Naghavi, Sepanlou (R30) 2022; 399 Yan (2025081810172476000_38.3.e102016.11) 2024; 337 2025081810172476000_38.3.e102016.46 2025081810172476000_38.3.e102016.47 Rockson (2025081810172476000_38.3.e102016.20) 2024; 26 Sajadi (2025081810172476000_38.3.e102016.32) 2019; 33 2025081810172476000_38.3.e102016.49 2025081810172476000_38.3.e102016.42 Kelishomi (2025081810172476000_38.3.e102016.45) 2024; 89 Effatpanah (2025081810172476000_38.3.e102016.13) 2024; 41 Amiri (2025081810172476000_38.3.e102016.27) 2022; 28 2025081810172476000_38.3.e102016.40 2025081810172476000_38.3.e102016.41 Li (2025081810172476000_38.3.e102016.12) 2023; 22 Danaei (2025081810172476000_38.3.e102016.31) 2019; 393 Khademi (2025081810172476000_38.3.e102016.48) 2020; 10 Gorji (2025081810172476000_38.3.e102016.43) 2014; 43 2025081810172476000_38.3.e102016.18 Liu (2025081810172476000_38.3.e102016.35) 2025; 55 2025081810172476000_38.3.e102016.10 Kokabisaghi (2025081810172476000_38.3.e102016.33) 2018; 7 Ghalichi (2025081810172476000_38.3.e102016.17) 2024; 12 2025081810172476000_38.3.e102016.51 Balata (2025081810172476000_38.3.e102016.7) 2024; 37 2025081810172476000_38.3.e102016.9 2025081810172476000_38.3.e102016.8 2025081810172476000_38.3.e102016.24 2025081810172476000_38.3.e102016.25 2025081810172476000_38.3.e102016.26 Moghaddasi Kelishomi (2025081810172476000_38.3.e102016.44) 2022; 151 2025081810172476000_38.3.e102016.21 Safiri (2025081810172476000_38.3.e102016.14) 2023; 56 Peng (2025081810172476000_38.3.e102016.19) 2023; 333 2025081810172476000_38.3.e102016.23 Zhao (2025081810172476000_38.3.e102016.29) 2024; 170 Amirkafi (2025081810172476000_38.3.e102016.16) 2024; 59 Alon (2025081810172476000_38.3.e102016.22) 2024; 335 Lu (2025081810172476000_38.3.e102016.6) 2024; 354 2025081810172476000_38.3.e102016.1 2025081810172476000_38.3.e102016.3 Amiri (2025081810172476000_38.3.e102016.15) 2025; 48 2025081810172476000_38.3.e102016.2 2025081810172476000_38.3.e102016.5 2025081810172476000_38.3.e102016.4 2025081810172476000_38.3.e102016.39 Amiri (2025081810172476000_38.3.e102016.50) 2022; 51 2025081810172476000_38.3.e102016.36 2025081810172476000_38.3.e102016.37 Gao (2025081810172476000_38.3.e102016.28) 2024; 331 2025081810172476000_38.3.e102016.38 2025081810172476000_38.3.e102016.34 2025081810172476000_38.3.e102016.30 |
| References_xml | – volume: 55 year: 2025 ident: R35 article-title: Global burden of mental disorders in children and adolescents before and during the COVID-19 pandemic: evidence from the Global Burden of Disease Study 2021 publication-title: Psychol Med doi: 10.1017/S0033291725000649 – volume: 170 start-page: 47 year: 2024 ident: R29 article-title: Global, regional, and national burden of depressive disorders among young people aged 10-24 years, 2010-2019 publication-title: J Psychiatr Res doi: 10.1016/j.jpsychires.2023.11.047 – volume: 9 start-page: 137 year: 2022 ident: R36 article-title: Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease study 2019 publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(21)00395-3 – volume: 59 start-page: 1113 year: 2024 ident: R16 article-title: Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings publication-title: Soc Psychiatry Psychiatr Epidemiol doi: 10.1007/s00127-023-02587-w – volume: 31 start-page: 39 year: 2011 ident: R49 article-title: Major depressive disorder: gender differences in symptoms, life quality, and sexual function publication-title: J Clin Psychopharmacol doi: 10.1097/JCP.0b013e318205a670 – volume: 56 start-page: 394 year: 2023 ident: R14 article-title: The estimated burden of bulimia nervosa in the Middle East and North Africa region, 1990-2019 publication-title: Int J Eat Disord doi: 10.1002/eat.23835 – volume: 331 start-page: 115668 year: 2024 ident: R28 article-title: Global, regional, and national trends in incidence of depression among women, 1990-2019: an analysis of the Global Burden of Disease Study publication-title: Psychiatry Res doi: 10.1016/j.psychres.2023.115668 – volume: 12 start-page: e1984 year: 2024 ident: R17 article-title: National and subnational burden of mental disorders in Iran (1990-2019): findings of the Global Burden of Disease 2019 Study publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(24)00342-5 – volume: 33 year: 2019 ident: R32 article-title: Universal health coverage in Iran: where we stand and how we can move forward publication-title: Med J Islam Repub Iran doi: 10.34171/mjiri.33.9 – volume: 17 start-page: 541 year: 2023 ident: R47 article-title: Brain-based sex differences in depression: a systematic review of neuroimaging studies publication-title: Brain Imaging Behav doi: 10.1007/s11682-023-00772-8 – volume: 354 start-page: 553 year: 2024 ident: R6 article-title: Global burden of depression or depressive symptoms in children and adolescents: a systematic review and meta-analysis publication-title: J Affect Disord doi: 10.1016/j.jad.2024.03.074 – volume: 48 start-page: 71 year: 2025 ident: R15 article-title: Mapping the burden of conduct disorder in the Middle East and North Africa: Global Burden of Disease Study 2021 publication-title: Compr Child Adolesc Nurs doi: 10.1080/24694193.2025.2472692 – volume: 52 start-page: 185 year: 2002 ident: R24 article-title: Biological risk factors in late life depression publication-title: Biol Psychiatry doi: 10.1016/s0006-3223(02)01349-5 – volume: 403 start-page: 2133 year: 2024 ident: R34 article-title: Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 publication-title: Lancet doi: 10.1016/S0140-6736(24)00757-8 – volume: 388 start-page: e19 year: 2016 ident: R39 article-title: Guidelines for accurate and transparent health estimates reporting: the GATHER statement publication-title: Lancet doi: 10.1016/S0140-6736(16)30388-9 – volume: 19 start-page: 335 year: 2000 ident: R40 article-title: Permutation tests for joinpoint regression with applications to cancer rates publication-title: Stat Med doi: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z – volume: 28 start-page: 3670 year: 2009 ident: R41 article-title: Estimating average annual per cent change in trend analysis publication-title: Stat Med doi: 10.1002/sim.3733 – volume: 335 start-page: 115854 year: 2024 ident: R22 article-title: Social determinants of mental health in major depressive disorder: umbrella review of 26 meta-analyses and systematic reviews publication-title: Psychiatry Res doi: 10.1016/j.psychres.2024.115854 – volume: 41 start-page: 121 year: 2024 ident: R13 article-title: Burden and epidemiology of mental disorders in the middle east and North Africa from 1990 to 2019: findings from the Global Burden of Disease study publication-title: Balkan Med J doi: 10.4274/balkanmedj.galenos.2024.2023-11-55 – volume: 403 start-page: 2162 year: 2024 ident: R51 article-title: Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 publication-title: Lancet doi: 10.1016/S0140-6736(24)00933-4 – volume: 151 start-page: 105760 year: 2022 ident: R44 article-title: Employment effects of economic sanctions in Iran publication-title: World Dev doi: 10.1016/j.worlddev.2021.105760 – volume: 51 start-page: 294 year: 2022 ident: R50 article-title: Unemployment and suicide mortality, suicide attempts, and suicide ideation: a meta-analysis publication-title: Int J Ment Health doi: 10.1080/00207411.2020.1859347 – volume: 7 start-page: 374 year: 2018 ident: R33 article-title: Assessment of the effects of economic sanctions on Iranians’ right to health by using human rights impact assessment tool: a systematic review publication-title: Int J Health Policy Manag doi: 10.15171/ijhpm.2017.147 – volume: 7 start-page: 3 year: 2011 ident: R4 article-title: The increasing burden of depression publication-title: Neuropsychiatr Dis Treat doi: 10.2147/NDT.S19617 – volume: 4 start-page: 146 year: 2017 ident: R46 article-title: Why is depression more common among women than among men? publication-title: Lancet Psychiatry doi: 10.1016/S2215-0366(16)30263-2 – volume: 399 start-page: 1625 year: 2022 ident: R30 article-title: Health system performance in Iran: a systematic analysis for the Global Burden of Disease Study 2019 publication-title: Lancet doi: 10.1016/S0140-6736(21)02751-3 – volume: 26 start-page: 101536 year: 2024 ident: R20 article-title: Prevalence of major depression and dysthymia among outpatient attendees at a tertiary healthcare psychiatric facility in South India publication-title: Clin Epidemiol Glob Health doi: 10.1016/j.cegh.2024.101536 – volume: 43 start-page: 381 year: 2014 ident: R43 article-title: Sanctions against Iran: the impact on health services publication-title: Iran J Public Health – volume: 61 start-page: 312 year: 2020 ident: R5 article-title: Annual research review: defining and treating pediatric treatment-resistant depression publication-title: J Child Psychol Psychiatry doi: 10.1111/jcpp.13202 – volume: 333 start-page: 524 year: 2023 ident: R19 article-title: The global, national, and regional burden of dysthymia from 1990 to 2019: insights from the Global Burden of Disease 2019 Study publication-title: J Affect Disord doi: 10.1016/j.jad.2023.04.024 – volume: 190 start-page: 293 year: 2007 ident: R26 article-title: Depression and socio-economic risk factors: 7-year longitudinal population study publication-title: Br J Psychiatry doi: 10.1192/bjp.bp.105.020040 – volume: 37 year: 2024 ident: R7 article-title: Depressive symptomatology, NT-proBNP levels and health status in patients with heart failure: a prospective observational study publication-title: Gen Psychiatr doi: 10.1136/gpsych-2024-101596 – volume: 22 year: 2023 ident: R12 article-title: Sex difference in incidence of major depressive disorder: an analysis from the Global Burden of Disease Study 2019 publication-title: Ann Gen Psychiatry doi: 10.1186/s12991-023-00486-7 – volume: 10 start-page: 33 year: 2020 ident: R48 article-title: Evaluating co-occurrence of depression and sexual dysfunction and related factors among Iranian rural women: a population-based study publication-title: Biomedicine (Taipei) doi: 10.37796/2211-8039.1003 – volume: 51 start-page: 8 year: 1994 ident: R1 article-title: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the national comorbidity survey publication-title: Arch Gen Psychiatry doi: 10.1001/archpsyc.1994.03950010008002 – volume: 160 start-page: 1147 year: 2003 ident: R21 article-title: Risk factors for depression among elderly community subjects: a systematic review and meta-analysis publication-title: Am J Psychiatry doi: 10.1176/appi.ajp.160.6.1147 – volume: 393 start-page: 1984 year: 2019 ident: R31 article-title: Iran in transition publication-title: Lancet doi: 10.1016/S0140-6736(18)33197-0 – volume: 89 start-page: 102581 year: 2024 ident: R45 article-title: Economic sanctions and informal employment publication-title: Labour Econ doi: 10.1016/j.labeco.2024.102581 – volume: 28 start-page: 2080 year: 2022 ident: R27 article-title: Unemployment associated with major depression disorder and depressive symptoms: a systematic review and meta-analysis publication-title: Int J Occup Saf Ergon doi: 10.1080/10803548.2021.1954793 – volume: 398 start-page: 1700 year: 2021 ident: R42 article-title: Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic publication-title: Lancet doi: 10.1016/S0140-6736(21)02143-7 – volume: 337 start-page: 115958 year: 2024 ident: R11 article-title: Global, regional, and national temporal trend in burden of major depressive disorder from 1990 to 2019: an analysis of the Global Burden of Disease Study publication-title: Psychiatry Res doi: 10.1016/j.psychres.2024.115958 – volume: 52 start-page: 175 year: 2002 ident: R23 article-title: Psychosocial risk factors for depressive disorders in late life publication-title: Biol Psychiatry doi: 10.1016/s0006-3223(02)01410-5 – ident: 2025081810172476000_38.3.e102016.46 doi: 10.1016/S2215-0366(16)30263-2 – volume: 354 start-page: 553 year: 2024 ident: 2025081810172476000_38.3.e102016.6 article-title: Global burden of depression or depressive symptoms in children and adolescents: a systematic review and meta-analysis publication-title: J Affect Disord doi: 10.1016/j.jad.2024.03.074 – ident: 2025081810172476000_38.3.e102016.34 doi: 10.1016/s0140-6736(24)00757-8 – ident: 2025081810172476000_38.3.e102016.47 doi: 10.1007/s11682-023-00772-8 – ident: 2025081810172476000_38.3.e102016.1 doi: 10.1001/archpsyc.1994.03950010008002 – ident: 2025081810172476000_38.3.e102016.38 – ident: 2025081810172476000_38.3.e102016.10 – volume: 22 year: 2023 ident: 2025081810172476000_38.3.e102016.12 article-title: Sex difference in incidence of major depressive disorder: an analysis from the Global Burden of Disease Study 2019 publication-title: Ann Gen Psychiatry doi: 10.1186/s12991-023-00486-7 – volume: 41 start-page: 121 year: 2024 ident: 2025081810172476000_38.3.e102016.13 article-title: Burden and epidemiology of mental disorders in the middle east and North Africa from 1990 to 2019: findings from the Global Burden of Disease study publication-title: Balkan Med J doi: 10.4274/balkanmedj.galenos.2024.2023-11-55 – volume: 43 start-page: 381 year: 2014 ident: 2025081810172476000_38.3.e102016.43 article-title: Sanctions against Iran: the impact on health services publication-title: Iran J Public Health – volume: 10 start-page: 33 year: 2020 ident: 2025081810172476000_38.3.e102016.48 article-title: Evaluating co-occurrence of depression and sexual dysfunction and related factors among Iranian rural women: a population-based study publication-title: Biomedicine (Taipei) doi: 10.37796/2211-8039.1003 – ident: 2025081810172476000_38.3.e102016.4 doi: 10.2147/NDT.S19617 – ident: 2025081810172476000_38.3.e102016.30 doi: 10.1016/S0140-6736(21)02751-3 – volume: 55 year: 2025 ident: 2025081810172476000_38.3.e102016.35 article-title: Global burden of mental disorders in children and adolescents before and during the COVID-19 pandemic: evidence from the Global Burden of Disease Study 2021 publication-title: Psychol Med doi: 10.1017/S0033291725000649 – volume: 170 start-page: 47 year: 2024 ident: 2025081810172476000_38.3.e102016.29 article-title: Global, regional, and national burden of depressive disorders among young people aged 10-24 years, 2010-2019 publication-title: J Psychiatr Res doi: 10.1016/j.jpsychires.2023.11.047 – volume: 333 start-page: 524 year: 2023 ident: 2025081810172476000_38.3.e102016.19 article-title: The global, national, and regional burden of dysthymia from 1990 to 2019: insights from the Global Burden of Disease 2019 Study publication-title: J Affect Disord doi: 10.1016/j.jad.2023.04.024 – ident: 2025081810172476000_38.3.e102016.3 – ident: 2025081810172476000_38.3.e102016.25 – ident: 2025081810172476000_38.3.e102016.5 doi: 10.1111/jcpp.13202 – ident: 2025081810172476000_38.3.e102016.39 doi: 10.1016/S0140-6736(16)30388-9 – ident: 2025081810172476000_38.3.e102016.23 doi: 10.1016/S0006-3223(02)01410-5 – volume: 337 start-page: 115958 year: 2024 ident: 2025081810172476000_38.3.e102016.11 article-title: Global, regional, and national temporal trend in burden of major depressive disorder from 1990 to 2019: an analysis of the Global Burden of Disease Study publication-title: Psychiatry Res doi: 10.1016/j.psychres.2024.115958 – ident: 2025081810172476000_38.3.e102016.18 – volume: 26 start-page: 101536 year: 2024 ident: 2025081810172476000_38.3.e102016.20 article-title: Prevalence of major depression and dysthymia among outpatient attendees at a tertiary healthcare psychiatric facility in South India publication-title: Clin Epidemiol Glob Health doi: 10.1016/j.cegh.2024.101536 – volume: 33 year: 2019 ident: 2025081810172476000_38.3.e102016.32 article-title: Universal health coverage in Iran: where we stand and how we can move forward publication-title: Med J Islam Repub Iran – ident: 2025081810172476000_38.3.e102016.9 – volume: 48 start-page: 71 year: 2025 ident: 2025081810172476000_38.3.e102016.15 article-title: Mapping the burden of conduct disorder in the Middle East and North Africa: Global Burden of Disease Study 2021 publication-title: Compr Child Adolesc Nurs doi: 10.1080/24694193.2025.2472692 – volume: 56 start-page: 394 year: 2023 ident: 2025081810172476000_38.3.e102016.14 article-title: The estimated burden of bulimia nervosa in the Middle East and North Africa region, 1990-2019 publication-title: Int J Eat Disord doi: 10.1002/eat.23835 – ident: 2025081810172476000_38.3.e102016.2 doi: 10.1136/bmj.i1617 – volume: 59 start-page: 1113 year: 2024 ident: 2025081810172476000_38.3.e102016.16 article-title: Drug-use disorders in the Eastern Mediterranean Region: a glance at GBD 2019 findings publication-title: Soc Psychiatry Psychiatr Epidemiol doi: 10.1007/s00127-023-02587-w – ident: 2025081810172476000_38.3.e102016.42 doi: 10.1016/S0140-6736(21)02143-7 – ident: 2025081810172476000_38.3.e102016.49 doi: 10.1097/JCP.0b013e318205a670 – volume: 393 start-page: 1984 year: 2019 ident: 2025081810172476000_38.3.e102016.31 article-title: Iran in transition publication-title: Lancet doi: 10.1016/S0140-6736(18)33197-0 – ident: 2025081810172476000_38.3.e102016.21 doi: 10.1176/appi.ajp.160.6.1147 – volume: 37 year: 2024 ident: 2025081810172476000_38.3.e102016.7 article-title: Depressive symptomatology, NT-proBNP levels and health status in patients with heart failure: a prospective observational study publication-title: Gen Psychiatr doi: 10.1136/gpsych-2024-101596 – ident: 2025081810172476000_38.3.e102016.51 doi: 10.1016/s0140-6736(24)00933-4 – volume: 89 start-page: 102581 year: 2024 ident: 2025081810172476000_38.3.e102016.45 article-title: Economic sanctions and informal employment publication-title: Labour Econ doi: 10.1016/j.labeco.2024.102581 – ident: 2025081810172476000_38.3.e102016.26 doi: 10.1192/bjp.bp.105.020040 – volume: 51 start-page: 294 year: 2022 ident: 2025081810172476000_38.3.e102016.50 article-title: Unemployment and suicide mortality, suicide attempts, and suicide ideation: a meta-analysis publication-title: Int J Ment Health doi: 10.1080/00207411.2020.1859347 – volume: 28 start-page: 2080 year: 2022 ident: 2025081810172476000_38.3.e102016.27 article-title: Unemployment associated with major depression disorder and depressive symptoms: a systematic review and meta-analysis publication-title: Int J Occup Saf Ergon doi: 10.1080/10803548.2021.1954793 – ident: 2025081810172476000_38.3.e102016.24 doi: 10.1016/S0006-3223(02)01349-5 – ident: 2025081810172476000_38.3.e102016.41 doi: 10.1002/sim.3733 – volume: 331 start-page: 115668 year: 2024 ident: 2025081810172476000_38.3.e102016.28 article-title: Global, regional, and national trends in incidence of depression among women, 1990-2019: an analysis of the Global Burden of Disease Study publication-title: Psychiatry Res doi: 10.1016/j.psychres.2023.115668 – volume: 7 start-page: 374 year: 2018 ident: 2025081810172476000_38.3.e102016.33 article-title: Assessment of the effects of economic sanctions on Iranians’ right to health by using human rights impact assessment tool: a systematic review publication-title: Int J Health Policy Manag doi: 10.15171/ijhpm.2017.147 – ident: 2025081810172476000_38.3.e102016.8 – ident: 2025081810172476000_38.3.e102016.36 doi: 10.1016/s2215-0366(21)00395-3 – volume: 335 start-page: 115854 year: 2024 ident: 2025081810172476000_38.3.e102016.22 article-title: Social determinants of mental health in major depressive disorder: umbrella review of 26 meta-analyses and systematic reviews publication-title: Psychiatry Res doi: 10.1016/j.psychres.2024.115854 – volume: 151 start-page: 105760 year: 2022 ident: 2025081810172476000_38.3.e102016.44 article-title: Employment effects of economic sanctions in Iran publication-title: World Dev doi: 10.1016/j.worlddev.2021.105760 – ident: 2025081810172476000_38.3.e102016.37 – ident: 2025081810172476000_38.3.e102016.40 doi: 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z – volume: 12 start-page: e1984 year: 2024 ident: 2025081810172476000_38.3.e102016.17 article-title: National and subnational burden of mental disorders in Iran (1990-2019): findings of the Global Burden of Disease 2019 Study publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(24)00342-5 |
| SSID | ssj0002116789 ssib041262867 ssib044737534 ssib048487736 |
| Score | 2.3022048 |
| Snippet | BackgroundMental disorders rank among the leading contributors to the global disease burden, with depressive disorders being among the most prevalent.AimsThe... Mental disorders rank among the leading contributors to the global disease burden, with depressive disorders being among the most prevalent. The objective of... Mental disorders rank among the leading contributors to the global disease burden, with depressive disorders being among the most prevalent.BackgroundMental... Background Mental disorders rank among the leading contributors to the global disease burden, with depressive disorders being among the most prevalent.Aims The... |
| SourceID | doaj pubmedcentral proquest pubmed crossref bmj |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | e102016 |
| SubjectTerms | Age groups Coronaviruses COVID-19 Depression Depressive Disorder Disease Emotional disorders Estimates Global Burden of Disease Incidence Mental depression Mental disorders Mental health Mood disorders Mortality Original Research Prevalence Sociodemographics Trends |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEF5ByoELD_EKFLRISByQ1WQfXpsLoqgVXKIKgdSb5dlHSUXtECcVf4F_zcx67RKEeuGYeC1NMrMz3-7MfMPYK00ow5UyM1ThSpmmrAYxzwplrdcBI0iwcdiEWSyK09PyJF24damscvCJ0VG71tId-QFlBHQu0ZzerX5kNDWKsqtphMZNtkdMZWrC9g6PFiefB4tSc0Gtl2OAVcpIxOejBaoC8brpJ35H3y0oLRHn5gnE9plG-DN02sj84CxWIKNhCYXuC0MnEZXAxflOTIvU___Cq3-XXf4Rx47v_u8_cI_dSQiWv-9N7j674ZsH7FdfW8uXDV-tiUGcHAavG8ch9knwNvCh6PbSc5c4P-MLnzBc8nrDh3vJ-Fq3hfHzdyps6t5yIgS5IGzMKfY63ja88z_jcvSKPDaodA_Z1-OjLx8-ZmnKQwaqKDeZQ4wYrDOFswYMhkrtpalnOZ57NGihYe6Cg1r7vFahJu4b5xCngAVpoEY08ohNmrbxTxi3EgIeP3Nq_1UqaBBl7u1MghWFFspO2WvUVpV2aVfFA5DMq16vFem16vU6ZW8GjVarnvbj2tWHpPRxJVF2xy_a9VmVPECFEoCYARgXEINqKLyxAM6W-HuC9ijc_qD2KwmvdD5lL8fH6AEorVM3vt3GNTKXVEIwZY97CxslQThOs6VRwmLH9nZE3X3SLL9FlvE5cfsjGn96vVzP2G1BI5FnOe6LfTbZrLf-ObtlLzfLbv0i7cff3RI61Q priority: 102 providerName: ProQuest |
| Title | Trends in prevalence and burden of depressive disorders in Iran at national and subnational levels: estimates based on sex and age groups |
| URI | https://gpsych.bmj.com/content/38/3/e102016.full https://www.ncbi.nlm.nih.gov/pubmed/40547356 https://www.proquest.com/docview/3222563793 https://www.proquest.com/docview/3223630127 https://pubmed.ncbi.nlm.nih.gov/PMC12182112 https://doaj.org/article/852b20bb7df6445b8e7cbbdc99ddf5ec |
| Volume | 38 |
| WOSCitedRecordID | wos001513859000001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2517-729X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002116789 issn: 2517-729X databaseCode: DOA dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2517-729X dateEnd: 99991231 omitProxy: false ssIdentifier: ssib044737534 issn: 2517-729X databaseCode: M~E dateStart: 20180101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2517-729X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002116789 issn: 2517-729X databaseCode: BENPR dateStart: 20180701 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 2517-729X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002116789 issn: 2517-729X databaseCode: M2M dateStart: 20180701 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2517-729X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002116789 issn: 2517-729X databaseCode: PIMPY dateStart: 20180701 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 2517-729X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002116789 issn: 2517-729X databaseCode: M2O dateStart: 20180701 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5B4cAFgXgZ2miRkDggq8mu17vujVat2kNChEAKJ8uzDwiiThUnFX-Bf92ZtR0SVMGFiyV719LEMzvzbWb2G8beKEIZrpCppgpXyjSlFYhRajJrvQoYQYKNzSb0ZGJms2K61eqLasJaeuD2wx0aJUAMAbQLGLoVGK8tgLNF4VxQ3pL3RdSztZkiHywovWCK_pSMzA-_xuphNAqRoevBsEckI3D5fSceRdr-27DmnyWTWzHo7BF72IFH_r4V-jG74-sn7Fdb1srnNb9aEnk3rVVe1Y5DPKLAF4H39a7XnruObjO-cIGRilcr3v8lGF9r1rC5_0E1Rc0RJy6OS4KlnMKe44uaN_5nnI4OicezIc1T9vns9NPJedo1WEghM8UqdQjPgnXaOKtBY5RSXupqmOOWQ4ESCkYuOKiUz6ssVEQ74xxCBLAgNVQIBJ6xvXpR-xeMWwkBd345nbzNsqBAFLm3QwlWoAYzm7C3-LHLboE0Zdx7yLxs1VKSWspWLQl71yukvGoZN_46-5h0tplJbNnxAdpQ2dlQ-S8bSth-r_HfElIKSuUS_VfCXm-GcfFRRqWq_WId58hcUvY-Yc9bA9lIgkiY2jqjhGbHdHZE3R2p598iwfeIaPURCL_8Hz_uFXsgqGfxMEfj32d7q-XaH7D79no1b5YDdlfPzIDdOz6dTD8O4iLC61iM4_UDjkwvxtMvN9hxJtg |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9NAFB6VggQXFgElUGCQQByQ1WQWj42EEFvVqG3EoUi9Gb-ZcQmidoiTAj-BP8Nv5L3xUoJQbz1wTDyOnp1v3jJv-Rh7rMnLcKmMDFW4UqYpykGMokRZ63WBFqSwgWzCTCbJ4WH6fo396nphqKyy04lBUbvK0hn5FmUEdCwRTi9nXyNijaLsakeh0cBi1__4hiFb_WL8Fv_fJ0Jsvzt4sxO1rAIRqCRdRA59ksI6kzhrwKBq1l6afBijn61BCw0jVzjItY9zVeQ0a8U5tItgQRrI0frh715gFxVGQkQVsS_60wE1EtTo2ZtzpYzEaKDHu0owOjANv3iwFIKSIIGlT2AkEWl0trq-HhlvHYV6Z4SxUKgs0VDTWBQ4_rxiQQPRwL-847-LPP-wmtvX_rf3fZ1dbf1z_qrZUDfYmi9vsp9N5TCflnw2p_nopA55XjoOoQuEVwXvSopPPHftRNNwwxidAZ4veHfqGm6rl9B__kJlW_VzTuNOjsnz5-RZOF6VvPbfw3LU-Ty039S32IdzefrbbL2sSn-HcSuhwOA6puZmpQoNIo29HUqwItFC2QF7iujIWh1UZyG8k3HW4CgjHGUNjgbsWYegbNYMNTlz9WsCWb-SBpKHL6r5UdbqtwwlADEEMK5AD1tD4o0FcDbF5ym0R-E2O5idSniKsQF71F9G_UZJq7z01TKskbGkAokB22gQ3UuCwQYxZ6OEyQrWV0RdvVJOP4UZ6iNiLsBY4-7Zcj1kl3cO9veyvfFk9x67Ioj8eRjjntxk64v50t9nl-zJYlrPHwRNwNnH894KvwHmnJfU |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VghAXHgJKoMAigTggK8l61-sgIQSUiKgQ9QBSb8azjxLU2mmcFPgJ_CV-HTPrRwlCvfXAMfE6GjvfzmPn8TH2WJGXYUdxpKnClTJNUQ5iGKXSGKc8WhBvAtmEnk7T_f3R3gb71fbCUFllqxODoraloTPyPmUEVBIjnPq-KYvY2xm_nB9HxCBFmdaWTqOGyK778Q3Dt-rFZAf_6ydCjN9-fPMuahgGIpDpaBlZ9E-8sTq1RoNGNa1crPNBgj63AiUUDK23kCuX5NLnNHfFWrSRYCDWkKMlxN-9wC5qqRSxJ3wQ3UmBHApq-uxMu5Q6xsigw75MMVLQNdd4sBqCEiKBsU9gVBEpdLzaHp846R-E2meEtJCoONFo04gUOPq6Zk0D6cC_POW_Cz7_sKDja__zu7_OrjZ-O39Vb7QbbMMVN9nPuqKYzwo-X9DcdFKTPC8sh9AdwkvP21LjE8dtM-k03DBBJ4HnS96exobbqhV0nw-pnKt6zmkMyhFFBJw8DsvLglfue1iOtoCHtpzqFvt0Lk9_m20WZeHuMG5i8Bh0J9T0LKVXIEaJM4MYjEiVkKbHniJSskY3VVkI--IkqzGVEaayGlM99qxFUzavh52cufo1Aa5bSYPKwxfl4iBr9F6GEoAYAGjr0fNWkDptAKwZ4fN45VC47RZypxKe4q3HHnWXUe9RMisvXLkKa-IkpsKJHtuq0d1JgkEIMWqjhOka7tdEXb9SzL6E2epDYjTAGOTu2XI9ZJdxB2TvJ9Pde-yKIE7oQYLbc5ttLhcrd59dMifLWbV4EJQCZ5_Peyf8Bub2oJo |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Trends+in+prevalence+and+burden+of+depressive+disorders+in+Iran+at+national+and+subnational+levels%3A+estimates+based+on+sex+and+age+groups&rft.jtitle=General+psychiatry&rft.au=Amiri%2C+Sohrab&rft.au=Khan%2C+Moien+A+B&rft.date=2025-06-20&rft.issn=2517-729X&rft.eissn=2517-729X&rft.volume=38&rft.issue=3&rft.spage=e102016&rft_id=info:doi/10.1136%2Fgpsych-2024-102016&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2517-729X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2517-729X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2517-729X&client=summon |